Evidence map›Paper›PMID 30845709›Full record

ReviewInternational journal of molecular sciences2019

Context-Dependent Effect of Glucocorticoids on the Proliferation, Differentiation, and Apoptosis of Regulatory T Cells: A Review of the Empirical Evidence and Clinical Applications.

Luigi Cari, Francesca De Rosa, Giuseppe Nocentini, Carlo Riccardi

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 2 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 2 syntheses or guidelines pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Glucocorticoid regulation of the mTORC1 pathway modulates CD4Clinical & translational immunology · 2023
    Article
  18. Steroid treatment suppresses the CD4Scientific reports · 2022
    Article
  19. New Insights on Effects of Glucocorticoids in Patients With SARS-CoV-2 Infection.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Luigi CariSection of Pharmacology, Department of Medicine, University of Perugia, Perugia I-06129, Italy. luigi.cari@hotmail.it.ORCID 0000-0003-0698-3872
Francesca De RosaSection of Pharmacology, Department of Medicine, University of Perugia, Perugia I-06129, Italy. francescaderosa94@libero.it.ORCID 0000-0001-5486-8217
Giuseppe NocentiniSection of Pharmacology, Department of Medicine, University of Perugia, Perugia I-06129, Italy. giuseppe.nocentini@unipg.it.ORCID 0000-0002-5209-0488
Carlo RiccardiSection of Pharmacology, Department of Medicine, University of Perugia, Perugia I-06129, Italy. carlo.riccardi@unipg.it.
University of Perugia · IT

Funding

Ministero dell'Istruzione, dell'Università e della Ricerca 2015ZT9MXY_001
6 · The paper itself

Abstract

Glucocorticoids (GCs) are widely used to treat several diseases because of their powerful anti-inflammatory and immunomodulatory effects on immune cells and non-lymphoid tissues. The effects of GCs on T cells are the most relevant in this regard. In this review, we analyze how GCs modulate the survival, maturation, and differentiation of regulatory T (Treg) cell subsets into both murine models and humans. In this way, GCs change the Treg cell number with an impact on the mid-term and long-term efficacy of GC treatment. In vitro studies suggest that the GC-dependent expansion of Treg cells is relevant when they are activated. In agreement with this observation, the GC treatment of patients with established autoimmune, allergic, or (auto)inflammatory diseases causes an expansion of Treg cells. An exception to this appears to be the local GC treatment of psoriatic lesions. Moreover, the effects on Treg number in patients with multiple sclerosis are uncertain. The effects of GCs on Treg cell number in healthy/diseased subjects treated with or exposed to allergens/antigens appear to be context-dependent. Considering the relevance of this effect in the maturation of the immune system (tolerogenic response to antigens), the success of vaccination (including desensitization), and the tolerance to xenografts, the findings must be considered when planning GC treatment.

Indexed as

AnimalsCell DifferentiationCell ProliferationCell SurvivalGlucocorticoidsHumansMiceT-Lymphocytes, RegulatoryGlucocorticoidsdesensitizing treatmentglucocorticoidshuman allergic diseaseshuman autoimmune diseasesperipherally derived Treg (pTreg) cellsregulatory T (Treg) cellsthymus-derived Treg cells (tTreg)tolerogenic responseTreg cell number modulation

Identifiers

PMID30845709
PMCPMC6429178
OpenAlexW2918864820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.